Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Infliximab

Morphea, psoriasiform dermatitis and genital lichen sclerosus: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Reinhart JP, et al. Tumor necrosis factor-alpha inhibitor-induced morphea and psoriasiform dermatitis in a pediatric patient with Crohn's disease. Pediatric Dermatology 40: 519-522, No. 3, May-Jun 2023. Available from: URL: http://doi.org/10.1111/pde.15182 [summarised from an abstract] Reinhart JP, et al. Tumor necrosis factor-alpha inhibitor-induced morphea and psoriasiform dermatitis in a pediatric patient with Crohn's disease. Pediatric Dermatology 40: 519-522, No. 3, May-Jun 2023. Available from: URL: http://​doi.​org/​10.​1111/​pde.​15182 [summarised from an abstract]
Metadaten
Titel
Infliximab
Morphea, psoriasiform dermatitis and genital lichen sclerosus: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41484-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Denosumab

Case report

Thalidomide

Case report

Prednisone

Case report

Tozinameran